Next Article in Journal
Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance
Next Article in Special Issue
Recent Developments in Pharmacotherapy of Depression: Bench to Bedside
Previous Article in Journal
Expanding Family Health History to Include Family Medication History
 
 
Review
Peer-Review Record

Recent Advances in Psychopharmacology: From Bench to Bedside Novel Trends in Schizophrenia

J. Pers. Med. 2023, 13(3), 411; https://doi.org/10.3390/jpm13030411
by Asim A. Shah 1,2 and Syed Z. Iqbal 3,*
Reviewer 1:
Reviewer 2: Anonymous
J. Pers. Med. 2023, 13(3), 411; https://doi.org/10.3390/jpm13030411
Submission received: 31 January 2023 / Revised: 22 February 2023 / Accepted: 23 February 2023 / Published: 25 February 2023
(This article belongs to the Special Issue Recent Advances in Psychopharmacology: From Bench to Bedside)

Round 1

Reviewer 1 Report

The manuscript deals with an important topic that is of interest to the audience of the journal. Reviewer has the following comments to make-

1. Based on the category of the manuscript (type of review), the inclusion of methodology is suggested to make sure that the review process was adequate and appropriate.

2. The table presented nicely depicted the novel approach. However, reviewers would suggest a table to present the unique characteristics of the group of medications (apart from receptor profiles) based on available limited data.

Author Response

Methodology part added as recommended , 

The unique charecteristics elaboration will be beyound the scope of this review as most of the noval compunds are still in developement process, and this can be done once they are fully approved by the FDA

Reviewer 2 Report

Very well done review. I only suggest to clearly report that this is a scoping review.

 

Author Response

The ammendment done as recommended by the reviewer 

Back to TopTop